The Valley Desk

ArticleFrontiers in nephrologyPublished

A randomized controlled trial of preemptive rituximab to prevent recurrent focal segmental glomerulosclerosis post-kidney transplant (PRI-VENT FSGS): protocol and study design

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Children’s Hospital of Philadelphia. Affiliation source

Publication record

Type
Article
Venue
Frontiers in nephrology
Published
Subject terms
Nephrotic syndrome; Focal Segmental Glomerulosclerosis; Kidney Transplant; Plasmapheresis; Recurrent Disease
PubMed ID
37675355
PubMed Central ID
PMC10479749
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal